Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Capital Expenditure Over TimeExpanding
Percentile Rank86
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-44000.00
↑ 85% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-301010.00
Historical baseline
PeriodValueYoY Change
TTM$-44000.00+45.0%
2024$-80000.00+86.3%
2023$-582000.00+34.8%
2022$-892000.00-335.1%
2021$-205000.00+2.8%
2020$-211000.00-210.3%
2019$-68000.00-1233.3%
2018$-5100.00+94.9%
2017$-100000.00+87.8%
2016$-823000.00-